NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA Conference

Tsien, Christina, Pugh, Stephanie, Dicker, Adam et al. (2019). NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA . Neuro-Oncology, 21 20-20.

cited authors

  • Tsien, Christina; Pugh, Stephanie; Dicker, Adam; Raizer, Jeffrey; Matuszak, Martha; Lallana, Enrico; Huang, Jiayi; Algan, Ozer; Taylor, Nicholas; Portelance, Lorraine; Villano, John; Hamm, John T; Oh, Kevin S; Ali, Arif N; Kim, Michelle; Lindhorst, Scott; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 20, 2019 -

publication date

  • November 1, 2019

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

start page

  • 20

end page

  • 20

volume

  • 21